236 related articles for article (PubMed ID: 2859332)
1. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
Isakov N; Bach FH
J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
[TBL] [Abstract][Full Text] [Related]
2. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
3. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
5. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
6. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
[TBL] [Abstract][Full Text] [Related]
7. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
8. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
Lowry RP; Gurley KE
Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
[TBL] [Abstract][Full Text] [Related]
9. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
[TBL] [Abstract][Full Text] [Related]
10. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
11. Genetic control of variability in responses to class-I-antigen-disparate thyroid grafts.
Isakov N; Bach FH
Transplantation; 1985 Mar; 39(3):303-9. PubMed ID: 3919481
[TBL] [Abstract][Full Text] [Related]
12. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of cultured thymic fragments. VI. H-2 recombinant donors.
Jenski LJ; Hong R
J Immunol; 1985 Aug; 135(2):947-53. PubMed ID: 2409162
[TBL] [Abstract][Full Text] [Related]
14. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.
Rosenberg AS; Finbloom DS; Maniero TG; Van der Meide PH; Singer A
J Immunol; 1990 Jun; 144(12):4648-50. PubMed ID: 2112572
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
Isakov N; Segal S
Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
[TBL] [Abstract][Full Text] [Related]
16. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
Williams IR; Perry LL
J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
[TBL] [Abstract][Full Text] [Related]
17. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
18. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
Ishikawa H; Saito K; Kubota E
J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
[TBL] [Abstract][Full Text] [Related]
19. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
20. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]